Fecal Transplant Capsules Nearly Double Immunotherapy Response Rates Across Three Cancer Types in Phase I/II Trials
Two companion trials published in Nature Medicine show oral FMT capsules raised immunotherapy response rates to 80% in lung cancer and 75% in melanoma, while reducing toxic side effects in kidney cancer.
5 min read3 sources